Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 7 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Sol-Gel Technologies Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 20 | 16 | −4 |
| Shares | 5.76M | 5.86M | +97.6K (+1.7%) |
| Value | $71.3M | $72.6M | +$1.21M (+1.7%) |
New holders (1)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exane Derivatives | 61 | $753 | 0.00% |
Sold out (5)
Institutions that held Sol-Gel Technologies Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Canada Pension Plan Investment Board | 19,800 | $245.0K |
| Proequities, Inc. | 1,000 | $12.0K |
| Bank of Montreal | 914 | $12.0K |
| Geneos Wealth Management Inc. | 200 | $2.00K |
| Tower Research Capital LLC (TRC) | 12 | $0 |